De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives

dc.contributor.author	Heim, Christopher
dc.contributor.author	Hernandez Alvarez, Birte
dc.contributor.author	Bär, Kerstin
dc.contributor.author	Hartmann, Marcus
dc.date.accessioned	2020-02-18T12:23:05Z
dc.date.available	2020-02-18T12:23:05Z
dc.date.issued	2019
dc.identifier.issn	1520-4804
dc.identifier.uri	http://hdl.handle.net/10900/98146
dc.language.iso	en	de_DE
dc.publisher	Amer Chemical Soc	de_DE
dc.relation.uri	http://dx.doi.org/10.1021/acs.jmedchem.9b00454	de_DE
dc.subject.ddc	540	de_DE
dc.title	De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_00509
utue.publikation.seiten	6615-6629	de_DE
utue.personen.roh	Heim, Christopher
utue.personen.roh	Pliatsika, Dimanthi
utue.personen.roh	Mousavizadeh, Farnoush
utue.personen.roh	Baer, Kerstin
utue.personen.roh	Alvarez, Birte Hernandez
utue.personen.roh	Giannis, Athanassios
utue.personen.roh	Hartman, Marcus D.
dcterms.isPartOf.ZSTitelID	Journal of Medicinal Chemistry	de_DE
dcterms.isPartOf.ZS-Issue	14	de_DE
dcterms.isPartOf.ZS-Volume	62	de_DE